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Objective: Metainflammation is a chronic low-grade inflammatory state induced by obesity and associated comorbidities, including peripheral
insulin resistance. Brown adipose tissue (BAT), a therapeutic target against obesity, is an insulin target tissue sensitive to inflammation.
Therefore, it is necessary to find strategies to protect BAT against the effects of inflammation in energy balance. In this study, we explored the
impact of moderate sirtuin 1 (SIRT1) overexpression on insulin sensitivity and b-adrenergic responses in BAT and brown adipocytes (BA) under
pro-inflammatory conditions.
Methods: The effect of inflammation on BAT functionality was studied in obese db/db mice and lean wild-type (WT) mice or mice with moderate
overexpression of SIRT1 (SIRT1Tgþ) injected with a low dose of bacterial lipopolysaccharide (LPS) to mimic endotoxemia. We also conducted
studies on differentiated BA (BA-WT and BA-SIRT1Tgþ) exposed to a macrophage-derived pro-inflammatory conditioned medium (CM) to evaluate
the protection of SIRT1 overexpression in insulin signaling and glucose uptake, mitochondrial respiration, fatty acid oxidation (FAO), and
norepinephrine (NE)-mediated-modulation of uncoupling protein-1 (UCP-1) expression.
Results: BAT from the db/db mice was susceptible to metabolic inflammation manifested by the activation of pro-inflammatory signaling
cascades, increased pro-inflammatory gene expression, tissue-specific insulin resistance, and reduced UCP-1 expression. Impairment of insulin
and noradrenergic responses were also found in the lean WT mice upon LPS injection. In contrast, BAT from the mice with moderate over-
expression of SIRT1 (SIRT1Tgþ) was protected against LPS-induced activation of pro-inflammatory signaling, insulin resistance, and defective
thermogenic-related responses upon cold exposure. Importantly, the decline in triiodothyronine (T3) levels in the circulation and intra-BAT after
exposure of the WT mice to LPS and cold was markedly attenuated in the SIRT1Tgþ mice. In vitro BA experiments in the two genotypes revealed
that upon differentiation with a T3-enriched medium and subsequent exposure to a macrophage-derived pro-inflammatory CM, only BA-SIRT1
Tgþ
fully recovered insulin and noradrenergic responses.
Conclusions: This study has ascertained the benefit of the moderate overexpression of SIRT1 to confer protection against defective insulin and
b-adrenergic responses caused by BAT inflammation. Our results have potential therapeutic value in combinatorial therapies for BAT-specific
thyromimetics and SIRT1 activators to combat metainflammation in this tissue.
 2020 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Current evidence has demonstrated that adipose tissue is a trigger for
the obesity-induced chronic low-grade inflammatory state known as
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tokines, adipokines, and reactive lipid species that negatively impact
whole body metabolism [1e3].
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Original Articleof lipids and glucose and dissipate energy as heat in a process known
as non-shivering thermogenesis mediated by the mitochondrial
uncoupling protein-1 (UCP-1) [4]. The study of BAT has exponentially
become more relevant since its re-discovery in adult humans [5e7].
The transcript levels of pro-inflammatory cytokines are lower in BAT
than in white adipose tissue (WAT), which probably reflects an
enhanced anti-inflammatory phenotype of BAT resident immune cells
[8]. However, increased levels of tumor necrosis factor (TNF)-a or
interleukin (IL)-1b [9e11] as well as insulin resistance [10] and
reduced energy expenditure [12] have been reported in BAT from
rodents under obesogenic conditions. Activation of BAT, either in
humans or rodent models, is associated with healthy systemic
metabolism [13,14]. In addition, the secretory capacity of BAT was
recently attributed to the modulation of its thermogenic capacity
[14e16].
Thyroid hormones (THs) are transcriptional activators of the Ucp1 gene
[17,18]. They are also essential to maintain norepinephrine (NE)-
mediated signaling in BAT by improving thermogenesis in brown ad-
ipocytes (BA) [19e21]. A recent study demonstrated a dual effect of
triiodothyronine (T3) in inguinal WAT (iWAT) in which it cooperates with
b-adrenergic signaling to induce the transcription of the Ucp1 gene in a
cAMP-dependent manner and also activates de novo lipogenesis
independently of cAMP signaling [22]. Thyromimetics that specifically
target BAT may be useful for its pharmacological activation [23]. Yau
et al. [24] extended the knowledge on the cell autonomous actions of
T3 in BA demonstrating its effects in increasing fatty acid oxidation
(FAO) and mitochondrial respiration. Other studies reported the impact
of inflammation on THs actions by administering bacterial lipopoly-
saccharide (LPS) to mice or pigs, which decreases the expression of
THs receptors in the heart [25] or THs levels in the serum and most
tissues [26]. The anti-inflammatory effect of THs was also reported in
humans [27].
Sirtuins are NADþ-dependent protein deacetylases involved in
fundamental biological processes such as development, metabolism,
aging, and associated diseases [28e31]. Several studies revealed
the beneficial effects of overexpressing the family member SIRT1 in
metabolic disorders. Because SIRT1 is an essential regulator of
systemic energy homeostasis, its pharmacological modulation could
be of interest to control diseases associated with metainflammation
[32]. In this sense, the moderate overexpression of SIRT1 in mice
deacetylates the RelA/p65 subunit of nuclear factor kappa B (NFkB)
and inhibits its activity in the liver, thereby attenuating inflammatory
responses in diet-induced obesity [33], supporting its anti-
inflammatory role. Moreover, browning of white adipocytes upon
cold exposure was reported in another model of SIRT1 transgenic
mice (SirBACO) [34] or in mice with genetic deletion of the SIRT1
endogenous inhibitor deleted in breast cancer 1 (Dbc1/) [35]. We
previously reported enhanced BAT activity in mice with constitutive
SIRT1 overexpression (SIRT1Tg/Tg mice) on a low-fat diet, supporting
a higher catabolic rate [36]. Conversely, SIRT1-deficient mice
showed the opposite effect with exacerbated BAT degeneration, cold
and glucose intolerance, and insulin resistance in response to a high-
fat diet (HFD) [37].
In the present study, we provided evidence that the moderate over-
expression of SIRT1 is sufficient to confer protection against defective
insulin and b-adrenergic responses caused by BAT inflammation. Of
note, this protection was associated with increased T3 content in this
fat depot. The beneficial effects of SIRT1 overexpression were also
assessed in a cell-autonomous manner in BA and full protection
against the deleterious effect of inflammation was achieved in cells
differentiated with a T3-enriched medium.2 MOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. T2. MATERIALS AND METHODS
2.1. Animal studies
All animal procedures were approved by the Ethics Committees of the
Spanish National Research Council of Madrid (Spain) in accordance
with the European Union’s guidelines. Dbþ and db/db male and fe-
male mice with C57BL/KsJ genetic backgrounds were purchased from
Charles Rivers Laboratories. C57Bl/6J mice overexpressing SIRT1
(SIRT1Tgþ) were provided by Dr. Manuel Serrano (CNIO, Madrid). Mice
were housed at the animal facilities at Instituto de Investigaciones
Biomédicas (IIBm) Alberto Sols (CSIC/UAM, Madrid) under controlled
conditions of 12 h:12 h lightedark cycles at 22 C and 45e55%
humidity and allowed free access to a standard rodent chow diet (A04,
U8220G10R, SAFE) and water.
The Dbþ and db/db mice (males and females, 7 weeks of age) were
treated with resveratrol (R5010, SigmaeAldrich) for 8 weeks. The
resveratrol was dissolved in their drinking water to a final concen-
tration of 50 mg/L and protected from light as previously described
[38]. The resveratrol dose was equivalent to approximately 2.5 mg/kg/
day. During our study, we confirmed that the mice were consuming the
amount of water necessary to reach the desired pharmacological
resveratrol dose [39]. Their body weights and glycemia were moni-
tored weekly.
Wild-type (WT) and SIRT1Tgþ male mice (2e5 months of age) were
fasted for 5 h and then intraperitoneally (i.p.) injected with 2 mg/kg
lipopolysaccharide (LPS, tlrl-eblps, InvivoGen) or saline (vehicle). The
mice were sacrificed at different time periods ranging from 30 min to
1 h to assess the activation of the pro-inflammatory signaling cascades
in BAT. One group of animals was maintained under control conditions
(22 C) without receiving LPS (-LPS). The other 2 groups were injected
with 2 mg/kg LPS (i.p.) and sacrificed after 30 min, 60 min, or 4 h (LPS
30 min, LPS 60 min, and LPS 4 h, respectively).
To analyze their in vivo insulin responses, the mice (dbþ, db/db, WT,
and SIRT1Tgþ) were fasted for 4 h, i.p. injected with 0.75 U/kg of
human recombinant human insulin (Actrapid, Novo Nordisk), and
sacrificed 20 min later. To analyze their insulin responses under pro-
inflammatory conditions, the WT and SIRT1Tgþmice were injected with
2 mg/kg LPS (i.p.) for 24 h and fasted for the last 4 h. The control group
did not receive LPS. After 24 h, the mice were injected with 0.75 U/kg
of insulin (i.p.) and sacrificed after 20 min. A subgroup of mice did not
receive insulin injections.
To analyze their thermogenic responses, the WT and SIRT1Tgþ mice
were housed at 28 C for one week and then subjected to a cold
challenge (4 C) for 6 h. To analyze the effect of LPS and cold expo-
sure, the WT and SIRT1Tgþmice were i.p. injected with 2 mg/kg of LPS
and sacrificed after 24 h. One subgroup of mice was exposed to the
cold during the last 6 h.
All mice were sacrificed and their BAT and different fat depots were
weighed and stored at 80 C until use. Blood was collected by
beheading in tubes with 20 mM of ethylenediaminetetraacetic acid
(EDTA).
2.2. Measurement of rectal and skin temperature surrounding BAT
Rectal temperature was measured with a rectal probe (RTC-1,
Cibertec). The skin temperature surrounding BAT was recorded with an
infrared camera (B335 compact infrared thermal imaging camera, FLIR
Systems, West Malling, Kent, UK) and analyzed with a software
package (FLIR Tools Software, FLIR Systems). Images were captured
and the temperature was measured at 28 C or immediately after cold
exposure (6 h). In the mice injected with LPS, the measurements were
recorded 24 h after the injection.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.3. Radioimmunoassays of T3 and T4 in plasma and BAT
Extraction of T3 and T4 from plasma or BAT tissue as well as T3 and
T4 determinations in plasma was conducted as previously described
[40]. (3e5)-T2 (D0629, SigmaeAldrich) and T3 (T2877, Sigmae
Aldrich) were used as substrates to obtain high specific activity
(3000 mCi/mg) 125I-T3 and
125I-T4, respectively, using
125I
(NEZ033A, PerkinElmer) as previously described [41,42] with minor
modifications [43]. THs from plasma were extracted with methanol
(1:6), subjected to evaporation, and resuspended in radioimmuno-
assay (RIA) buffer (0.04 M of phosphate buffer and pH 8), with 0.2%
bovine serum albumin (BSA) and 0.6 mM of merthiolate (T-5125,
SigmaeAldrich). For the extraction and purification of THs from BAT,
frozen tissue samples (70e100 mg) were homogenized in meth-
anol. THs were extracted using chloroform-methanol (2:1), back-
extracted into an aqueous phase, and purified using AG 1-X2
resin (1401251, Bio-Rad) in custom-made columns using a pH
gradient. The acetic extracts were then evaporated to dryness and
dissolved in RIA buffer. The extracts were kept frozen until further
analysis by highly sensitive RIA to determine T3 and T4 (dynamic
range: 0.4e100 pg T3/tube and 2.5e320 pg T4/tube). The radio-
activity was quantified in a gamma counter (Cobra II B5003,
Packard). The concentrations were calculated using the amounts of
T3 and T4 detected in the RIAs. The recovery of the [
125I]-T4 and
[125I]-T3 was added to tracer samples, and the weights of the tissue
samples were extracted.
2.4. Histological analysis and immunostaining
Hematoxylin and eosin (H&E) staining was performed in paraffin
sections of BAT from the WT and SIRT1Tgþ mice. BAT tissue was
fixed in 4% paraformaldehyde (PFA, 16005, SigmaeAldrich) for 24 h,
washed twice with PBS, dehydrated with ascending ethanol solu-
tions, incubated with xylene, and then embedded in paraffin. Blocks
were cut into 5 mm sections. Prior to H&E staining or immunohis-
tochemistry, the sections were deparaffinized in xylene and hydrated
in descending ethanol solutions and distilled water. The slides were
stained with Mayer’s hematoxylin (MHS32-1L, SigmaeAldrich) for
15e20 min and eosin (1.15935.0025, Merck) for 1 min. After the
slides were dried and mounted, the images were captured with an
Axiophot light microscope (Zeiss) using a 40 objective. To estimate
the cell density, the nuclei were counted in 3 fields of different BAT
sections of each animal using ImageJ software (National Institutes of
Health; https://imagej.nih.gov/ij/). Approximately 200 total nuclei per
section were counted.
For UCP-1 immunohistochemistry, sections were heated for 20 min in
100 mM of sodium citric buffer (pH 6.0) and 0.05% Tween-20. After
washing with PBS, endogenous peroxidase was blocked by incubation
with a solution of 9% H2O2 in 10% methanol for 10 min at room
temperature. The tissue sections were then incubated in 6% BSA and
2% normal horse serum (NHS) in PBS-0.1% Triton X-100 for 1 h at
room temperature to block non-specific binding. The sections were
incubated with primary antibody against UCP-1 (1:500, Ab10983,
Abcam) overnight at 4 C. The sections were washed with PBS and
incubated with biotinylated secondary anti-rabbit (1:250) (BA-1100,
Vector Laboratories) for 1 h at room temperature. After washing with
PBS, the slides were incubated with DAB-immunoperoxidase staining
(SK-4100, Vector Laboratories). After washing with water for 5 min,
the sections were counterstained with hematoxylin (H3136, Sigmae
Aldrich) solution for 10 s and rinsed again with water. After dehydration
and xylene incubation, the sections were assembled with DePeX
(18243.02, SERVA Electrophoresis GmbH), covered with coverslips,
and dried overnight.MOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. This is an open
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from the WT and SIRT1Tgþ mice
WT and SIRT1Tgþ brown preadipocyte cell lines were generated as
previously described [36]. The detailed protocol is described in the
Supplementary Materials and Methods section. Immortalized pre-
adipocytes were maintained in DMEM supplemented with 100 U/mL
penicillin, 100 mg/mL streptomycin, 10 mM HEPES, and 10% FBS.
Cells were plated in DMEM supplemented with 10% FBS, 1 nM of T3
(T6397, SigmaeAldrich), and 20 nM of insulin. This medium was
called medium 1. For differentiation, the cells were grown until 90%
confluence followed by two differentiation protocols.
In protocol 1, cells were stimulated for 36 h with differentiation me-
dium 1 containing medium 1 supplemented with 0.5 mM of dexa-
methasone (D1756, SigmaeAldrich), 1 mM of rosiglitazone (R2408,
SigmaeAldrich), 0.5 mM of isobutylmethylxanthine (IBMX) (I5879,
SigmaeAldrich), and 0.125 mM of indomethacin (I7378, Sigmae
Aldrich). The cells were then cultured back into medium 1 for 3 more
days.
In protocol 2, cells were stimulated for 36 h with differentiation me-
dium 2 containing medium 1 supplemented with 35 nM of dexa-
methasone, 10 mM of rosiglitazone, 2.99 mM of T3, and 830 nM of
insulin. The cells were then maintained in DMEM supplemented with
10% FBS, 10 mM of rosiglitazone, 3 mM of T3, and 850 nM of insulin for
3 days (called medium 2). This protocol was adapted from [44].
Differentiated brown adipocytes (BA) were called BA-WT and BA-
SIRT1Tgþ.
2.6. Production of pro-inflammatory conditioned medium by
macrophages
The murine macrophage cell line Raw 267.4 was used to obtain a pro-
inflammatory conditioned medium (CM). The Raw 264.7 cells were
maintained in 10 cm culture dishes with Roswell Park Memorial
Institute (RPMI) medium supplemented with 100 U/mL of penicillin,
100 mg/mL of streptomycin, 10 mM of HEPES, 2 mM of L-glutamine,
and 10% FBS. Macrophages were grown until 95e100% confluence
was reached. Then the medium was changed to RPMI-2% FBS for 1 h
and the macrophages were treated with 100 ng/mL of LPS for 5 h or
left untreated. The culture medium was then removed and the cells
were washed with phosphate-buffered saline (PBS) and cultured in
RPMI-2% FBS medium for 17 h (referred as CM-LPS or CM-CTR,
respectively). Both CM were filtered and supplemented with FBS
(final 5%) before the addition of BA. Aliquots of each CM (CM-LPS or
CM-CTR) were collected and mixed with 1 mM of sulfanilic acid
(151057.1208, Panreac) and 1 mM of N-(l-naphthyl) ethylenediamine
(NEDA) (N912510G, SigmaeAldrich). Nitrite production was measured
spectrophotometrically at 548 nM and the concentration was deter-
mined using a standard NO2 curve.
2.7. Insulin signaling in brown adipocytes
To analyze the insulin signaling in differentiated BA, cells were serum-
starved for 1 h in DMEM following stimulation with 10 nM of insulin for
15 min. To assess the insulin response under pro-inflammatory con-
ditions, BA were treated with CM-CTR or CM-LPS for 17 h. After serum
starvation for 1 h in DMEM, the cells were stimulated with 10 nM of
insulin for 15 min. At the end of the treatments, the cells were lysed
and processed.
2.8. Measurement of glucose uptake in brown adipocytes
Differentiated BA were treated with CM-CTR or CM-LPS for 17 h and
after the cells were serum deprived for 1 h. The cells were then
washed twice with KrebseRinger phosphate buffer (KRP) (135 mM ofaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 3
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sodium pyrophosphate, and pH 7.4) and incubated with KRP buffer for
15e30 min at 37 C. After stimulation with 10 nM of insulin for
10 min, 2-deoxy-D [13H] glucose (500 nCi/mL) was added for 5 more
min. Control cells were maintained in the absence of insulin stimula-
tion. The cells were washed twice with KRP buffer and solubilized with
a syringe in 1% (p/v) SDS. After 2 h of incubation at 37 C, the
radioactivity was measured by liquid scintillation counting. Total pro-
tein was determined by the BCA method and the results were
normalized to the protein amount in each culture plate.
2.9. Analysis of thermogenic responses in brown adipocytes
To analyze the UCP-1 expression in BA, cells were differentiated with
protocols 1 or 2. Once differentiated, BA were cultured in DMEM
supplemented with 5% FBS for 1 h and then stimulated with 5 mM of
norepinephrine (NE, A9512, SigmaeAldrich) for 17 h or left untreated.
To study the impact of a pro-inflammatory environment on the ther-
mogenic responses, BA were cultured with CM-CTR or CM-LPS in the
absence or presence of 5 mM of NE for 17 h. At the end of the
treatments, the cells were lysed and processed.
2.10. Measurement of bioenergetic profile
The oxygen consumption rate (OCR) was measured in BAT explants
from the WT and SIRT1Tgþ mice. The mice were injected with 2 mg/kg
of LPS 24 h before the OCR analyses. The control mice did not receive
LPS. BAT was excised and cut using a scalpel into 9 mg pieces and
placed into a tube containing DMEM supplemented with 25 mM of
glucose and 25 mM of Hepes. Tissues were kept in this medium (wash
medium) until the measurement of respiration. The capture screens
(Seahorse Bioscience, North Billerica, MA, USA) were pre-wet in wash
medium in a small petri dish to remove air bubbles. A pair of sterile
forceps was used to position the screens (ring facing up) in a new
empty small petri dish, and 9 mg of BAT was placed on the screen
using the forceps. The capture screen insert tool (Seahorse Bioscience)
was used to pick up the tissue-containing screens from the petri dish
and place them in an XF24 Islet Capture Microplate (Seahorse
Bioscience). Once in position, 450 mL of assay medium (DMEM sup-
plemented with 25 mM of glucose) was added to the samples. For a
typical bioenergetic profile, a set of inhibitors (all from SigmaeAldrich)
of key components of cellular respiration was added: 24 mg/mL of
oligomycin A, 0.8 mM of FCCP uncoupler, and a mix of 5 mM of
rotenone and 15 mM of antimycin A for BAT explants.
To analyze the OCR in BA, cells were differentiated with medium 1 or 2
in customized Seahorse 24-well plates and stimulated with CM-CTR
and CM-LPS for 18 h. Before any measurement, the cells were
incubated for 1 h with XF Assay Medium (Seahorse Bioscience) plus
5 mM of glucose. We followed the protocol and injection strategies of
the Mito Stress Assay (Seahorse Bioscience). The concentrations of the
inhibitors were 2 mM of oligomycin (75351, SigmaeAldrich), 2 mM of
FCCP uncoupler (C2920, SigmaeAldrich), and a mix of 10 mM of
rotenone (R8875, SigmaeAldrich) and 10 mM of antimycin-A (A8674,
SigmaeAldrich) for mature BA.
The OCR was calculated by plotting the O2 tension of media as a
function of the time (pmol/min), and the data were normalized by the
protein concentration measured in each individual well using Brad-
ford’s method. Calculations were conducted as previously described
[45] using Agilent Seahorse Wave Desktop software.
2.11. Fatty acid oxidation (FAO) analysis
Palmitate oxidation to CO2 and acid-soluble products (ASPs),
essentially acyl-carnitine, Krebs cycle intermediates, and acetyl-CoA,4 MOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. Twas measured in BA-WT and BA-SIRT1Tgþ grown and differentiated
in 24-well plates. The day of the assay, the cells were washed in
KrebseRinger bicarbonate Hepes buffer (KRBH buffer: 135 mM of
NaCl, 3.6 mM of KCl, 0.5 mM of NaH2PO4, 0.5 mM of MgSO4, 1.5 mM
of CaCl2, 2 mM of NaHCO3, 10 mM of HEPES, and pH 7.4) and 0.1%
of BSA, preincubated at 37 C for 30 min in KRBH-1% BSA, and
washed again in KRBH-0.1% BSA. The cells were then incubated for
3 h at 37 C with fresh KRBH containing 25 mM of glucose, 8 mM of
carnitine (C0283, SigmaeAldrich), 2.5 mM of palmitate, and 1 mCi/
mL of [1e14C] palmitate (CFA23, Amersham Pharmacia Biotech)
bound to BSA. Oxidation measurements were conducted as previ-
ously described [46] with minor modifications by trapping the
radioactive CO2 in a 1 cm
2 Whatman paper soaked with 100 mL of
0.1 N KOH using a parafilm-sealed system. The reaction was stopped
by adding 40% perchloric acid through a syringe that pierced the
parafilm. The following day, the system was opened and the papers
were left to dry before transferring them into tubes with 5 mL of
scintillation liquid (6013159, Perkin Elmer). Then 300 mL of the re-
action mix with perchloric acid was removed and centrifuged at the
maximum speed for 10 min. Then 150 mL of the supernatant that
contained the ASPs was transferred into a tube containing 5 mL of
scintillation liquid. After 2 h of stabilization, the samples were
analyzed and the CO2 data were expressed as nmol palmitate mg
1
prot * h1 ¼ (cpmsample - cpmblanc) * 80/(total cpm * mg prot * h).
The ASP results were expressed as nmol palmitate mg1 prot *
h1¼ (cpmsample - cpmblanc) * 80 * (352/150)/(total cpm *mg prot *
h) as previously described [46].
2.12. Analysis of protein expression by Western blotting
The detailed protocols for the protein analysis are described in the
Supplementary Materials and Methods section.
2.13. Semi-quantitative and quantitative real-time PCR analysis
The detailed protocols for the real-time PCR analysis are described in
the Supplementary Materials and Methods section.
2.14. Analysis of mitochondrial markers by immunofluorescence
BA were differentiated with medium 1 or 2 in sterile round glass
coverslips and fixed with 4% PFA at pH 7.5 for 20 min at room
temperature. After washing with PBS, the cells were permeabilized
with 0.1% sodium citrate at pH 6 and 0.1% Triton X-100 for TOM 22
and COX-IV immunofluorescence or with 0.1% Triton X-100 in PBS for
MFN2 and p-DRP1 immunofluorescence for 5 min at room tempera-
ture. After washing with washing buffer (0.25% BSA and 0.1% Tween-
20 in PBS) for 10 min, the cells were blocked for 30 min at room
temperature with 2.4% BSA in washing solution for TOM 22 and COX-
IV or with 5% normal goat serum (NGS, ab7481, Abcam) and 5% BSA
in PBS for MFN2 and p-DRP1. The cells were then incubated with
primary antibodies ((TOM 22, (T6319, SigmaeAldrich), COX-IV
(1D6ElA9, Thermo Fisher Scientific), p-DRP1 (3455, Cell Signaling),
or MFN2 (ab56889, Abcam)) at 1:200 dilution in blocking solution
overnight at 4 C and the incubation continued the following day for
30 min at room temperature. After washing twice with PBS, the cells
were incubated with fluorochrome-conjugated secondary antibodies
((goat anti-rabbit Alexa 488 (A11034, Thermo Fisher Scientific) for
TOM 22, goat anti-mouse Alexa 488 (A11029, Thermo Fisher Scien-
tific) for COX-IV), goat anti-rabbit Alexa 647 (A21245, Thermo Fisher
Scientific) for p-DRP1, and goat anti-mouse Alexa 488 (A11029,
Thermo Fisher Scientific) for MFN2)) at 1:250 dilution in blocking buffer
with DAPI (1 mg/mL, 62248, Thermo Fisher Scientific) for 1 h at room
temperature. Coverslips were adhered with antifade mounting mediumhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(00-4958-02, Thermo Fisher Scientific), allowed to dry overnight, and
then maintained at 4 C until confocal microscopy analysis.
2.15. Staining of lipid droplets with Bodipy
BA were differentiated with medium 1 or 2 and incubated with 1e
5 mg/mL of Bodipy dye (D3835, Thermo Fisher Scientific) dilution for
30 min at 37 C. The cells were washed twice with PBS, fixed with 4%
PFA at pH 7.5 for 20 min at room temperature, and then incubated with
DAPI (1 mg/mL) for 5 min at room temperature. Coverslips were
adhered with antifade mounting medium, allowed to dry overnight, and
then maintained at 4 C until confocal microscopy analysis.
2.16. Flow cytometry
BA were incubated with 100 nM of MitoTracker Green (MTG, M7514,
Thermo Fisher Scientific) for 30 min at 37 C. After washing with PBS,
the cells were trypsinized, neutralized, and centrifuged at 238g. The
pellet was resuspended in PBS and the relative MTG fluorescence was
determined by flow cytometry (FACSCanto, Becton Dickinson) and
FACS Diva (Becton Dickinson) software.
2.17. Lipolysis assay
BA were stimulated for 18 h with DMEM-5% FBS and then incubated
with KrebseRinger Modified Buffer (KRB) (118.5 mM of NaCl, 4.75 mM
of KCl, 1.92 mM of CaCl2, 1.19 mM of KH4PO4, 1.19 mM of
MgSO4(H2O)7, 25 mM of NaHCO3, 10 mM of HEPES, 6 mM of D-
glucose, 4% BSA, and pH 7.4) and 5 mM of NE was added for the last
4 h. Supernatants were collected and the amount of glycerol was
quantified spectrophotometrically at 540 nm with a Free Glycerol
Reagent colorimetric kit (12812, BioSystems). The amount of glycerol
was determined using a commercial standard solution and normalized
to the protein amount of each sample.
2.18. Measurement of ATP levels
Cells were lysed in cold Milli-Q water, heated to 80 C for 5 min, and
centrifuged at 134g for 5 min. The ATP levels were detected using a
bioluminescence kit (ATP determination kit, PRO (LBR-PO10)) following
manufacturer’s instructions (Biaffin GMbH & Co. KG). The chem-
iluminescence generated was detected at a 560 nm wavelength in a
luminometer (GloMax 96 Microplate Luminometer, 9101-002, Prom-
ega). A curve with increasing concentrations of ATP was used to
calculate the amount of ATP in each sample.
2.19. GC/MS-targeted metabolomics
Metabolomic studies are described in the Supplementary Materials and
Methods section.
2.20. Analysis of FGF21 plasma levels
FGF21 plasma levels were quantified by ELISA (RD291108200R,
BioVendor) following the manufacturer’s instructions. Samples were
collected from the dbþ and db/db mice treated with resveratrol or not
for 8 weeks and after 4 h of fasting.
2.21. Statistical analysis
Statistical analysis was conducted using GraphPad Prism software
versions 5 and 8 (GraphPad Software Inc., San Diego, CA, USA). The
D’Agostino-Pearson omnibus normality test was run to determine if the
samples showed a parametric or non-parametric distribution. Manne
Whitney U test was used to conduct pairwise comparisons in the non-
parametric distributions. Two-way ANOVA with Bonferroni’s post hoc
test was employed to compare two different categorical independent
variables. The data are presented as mean  SEM (standard error ofMOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. This is an open
www.molecularmetabolism.comthe mean). Statistical significance was set at *,#p < 0.05,
**,##p < 0.01, and ***,###p < 0.001.
3. RESULTS
3.1. BAT from the db/db mice showed activation of pro-
inflammatory signaling cascades and reductions in UCP-1 and
insulin signaling
We initially conducted studies in the db/db mice, a genetic model with
key features of obesity, metainflammation, and type 2 diabetes mel-
litus (T2DM). As previously reported [47,48], the db/db mice had
obesity and hyperglycemia (Figure. S1AeB) compared to their dbþ
lean counterparts concurrently with higher adiposity (BAT, iWAT, and
eWAT) (Figure. S1CeE). Moreover, phosphorylated levels of kinases
related to inflammatory states such as STAT3, IKKa/b, JNK, and p38
MAPK were significantly elevated in BAT extracts from the db/db mice
compared to the dbþ controls (Figure 1A). This pro-inflammatory
signature was also manifested by increased mRNA expression of
Tlr4, Il6, and Nos2 (Figure 1B). Supporting an impaired BAT function
associated with its inflammatory state, the UCP-1 protein content was
decreased in the db/db mice (Figure 1C).
We next studied whether inflammation impaired insulin signaling in
BAT from the db/db mice. Our data showed that phosphorylation of IR
and AKT was significantly reduced in BAT from the db/db mice
receiving an i.p. insulin injection (Figure 1D). It is well-known that IR is
expressed in cells in two different isoforms containing or not exon 11
(IRB and IRA, respectively) [49]. Although both isoforms have a similar
affinity for insulin, IRA is an immature form that exhibits a higher af-
finity for IGFs. The two IR isoforms were detected in BAT from both
groups, but the db/db mice showed a robust presence of IRA
(Figure 1E) that could account, at least in part, for the attenuated in-
sulin signaling.
3.2. Moderate SIRT1 overexpression ameliorated the effects of LPS
on BAT inflammation
As endotoxemia is an important component of obesity-induced met-
ainflammation [50], we evaluated whether it is sufficient to activate
pro-inflammatory signaling cascades in BAT, an issue less investi-
gated. To achieve this, we mimicked this condition by injecting a low
dose of LPS (2 mg/kg) into the wild-type (WT) and mice with a
moderate overexpression of SIRT1 (SIRT1Tgþ) due to their protection
against obesity-induced metabolic damage [33]. Figure 2A shows that
the SIRT1 protein levels increased (wthreefold) in BAT from the
SIRT1Tgþ mice. Phosphorylation of STAT3, IKKa/b, JNK, and p38
MAPK rapidly increased in BAT upon LPS challenge; however, the
effect on STAT3 and p38 MAPK was ameliorated in the SIRT1Tgþ mice
(Figure 2B). In addition, the impact of LPS on the elevation of mRNA
levels encoding the pro-inflammatory cytokines IL-6 and TNF-a was
attenuated in BAT from the SIRT1Tgþ mice (Figure 2C).
We determined the impact of LPS-mediated inflammation and mod-
erate SIRT1 overexpression in insulin signaling in BAT. The WT and
SIRT1Tgþ mice were injected with LPS and after 24 h, a subgroup of
animals received an insulin injection. Both genotypes similarly
responded to insulin in inducing IR and AKT phosphorylation
(Figure S2). Notably, whereas LPS reduced IR and AKT phosphorylation
in BAT from the WT mice compared with their genotype counterparts
that did not receive LPS (Figure 2D), the SIRT1Tgþmice were protected
against the decrease in LPS-mediated insulin signaling. When the 2
genotypes receiving LPS were compared, insulin-induced AKT phos-
phorylation was significantly increased in the SIRT1Tgþ mice
(Figure S2).access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 5
Figure 1: BAT from the db/db mice showed inflammatory features and insulin resistance. (A) Representative Western blotting and quantification of STAT3, IKKa/b, JNK, and
p38 MAPK phosphorylation in BAT from the dbþ and db/db mice (n ¼ 4e8 mice/group). (B) Tlr4, Il6, and Nos2 mRNA expression in BAT (n ¼ 3e7 mice/group). (C) Representative
Western blotting and quantification of UCP-1 protein levels in BAT (n ¼ 4e7 mice/group). (D) Representative Western blotting and quantification of IR and AKT phosphorylation in
BAT (n ¼ 2e6 mice/group). (E) Pattern of IR isoforms and quantification of the IRA/IRB ratio (n ¼ 7e10 mice/group). Data are expressed as mean  SEM. The statistical analysis
was conducted with the ManneWhitney U test. *p < 0.05, **p < 0.01, and ***p < 0.001.
Original ArticleTo study the effects of endotoxemia and moderate SIRT1 over-
expression in the thermogenic response of BAT, the mice were housed
at 28 C for one week. One group of each genotype received an LPS
injection, and all the groups maintained at 28 C were sacrificed after
24 h. A slight decrease in the rectal temperature was detected in the
LPS-injected WT mice, but not in the SIRT1Tgþ mice that also showed6 MOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. Thigher temperatures in the skin BAT area regardless of the LPS
treatment (Figure S3A). Interestingly, histological analysis of BAT
sections revealed an increased number of nuclei per field, indicative of
higher cell density, in the control or LPS-injected SIRT1Tgþ mice
compared to the WT mice (Figure S3B). However, although the Ucp1
mRNA levels were not significantly modulated by LPS, a tendency ofhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Moderate SIRT1 overexpression ameliorated the effects of LPS in BAT. (A) Western blotting of SIRT1 in BAT and quantification (n ¼ 4 mice/group). (B) Western
blotting analysis and quantification of STAT3, JNK, and p38 MAPK phosphorylation in BAT of the WT and SIRT1Tgþ mice intraperitoneally (i.p.) injected with LPS (2 mg/kg) and
sacrificed at different time periods (n ¼ 2e5 mice/group). (C) Il6 and Tnfa mRNA expression in BAT (n ¼ 4 mice/group). (D) Western blotting and quantification showing levels of
insulin-induced IR and AKT (Ser 473) phosphorylation after LPS and insulin injections (n ¼ 5e6 mice/group). (E) Western blotting and quantification of UCP-1 protein expression in
BAT from the mice receiving LPS or not and exposed to 4 C for the last 6 h (n ¼ 8e10 mice/group). The right panel shows UCP-1 immunohistochemistry images (n ¼ 3 mice/
group). (F) The graphs show skin temperature of the BAT area and rectal temperature (n ¼ 7e17 mice/group). The middle panel shows representative images. (G) Nuclei
quantification in different BAT sections (3e4 mice/group). The right panel shows representative H&E staining BAT images. Scale bars represent 50 mm. Data are expressed as
mean  SEM. Statistical analysis in A, D, and E was conducted with the ManneWhitney U test. Statistical analysis in B, C, F, and G was performed by two-way ANOVA.
*Comparisons between LPS-treated and untreated mice with the same genotype. #Comparison between genotypes receiving the same treatment. *,#p < 0.05, **,##p < 0.01, and
***p < 0.001.
MOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 3: SIRT1 overexpression conferred protection against insulin resistance, but not UCP-1 induction, in brown adipocytes under pro-inflammatory conditions. (A)
Western blotting and graphs showing IR and AKT phosphorylation in BA with or without insulin (n ¼ 3e4 independent experiments). (B) Western blotting and quantification of
PTP1B and SIRT1 (n ¼ 7e8 independent experiments). (C) Western blotting and quantification of fold change of UCP-1 (protein and mRNA) after NE stimulation (n ¼ 3e4
independent experiments). (D) Glycerol released after NE stimulation (n ¼ 3 independent experiments). (E) Western blotting and quantification of insulin-induced IR and AKT
phosphorylation after CM-CTR or CM-LPS treatment (n ¼ 3e4 independent experiments). (F) The left graph represents the basal 3H-2-deoxyglucose uptake in BA (n ¼ 4 in-
dependent experiments) and the right graphs represent the fold increase in insulin-induced glucose uptake after treatment with CM-CTR or CM-LPS for 18 h and further stimulated
with insulin (10 nM) (n ¼ 4 independent experiments). (G) Western blotting and graphs showing the fold increase in UCP-1 (protein and mRNA) after NE stimulation (n ¼ 3e5
independent experiments). Results are expressed as mean  SEM. The statistical analysis in A, E, F (left graph), and G (right graphs) was performed by two-way ANOVA.
*Comparisons between treated and untreated BA with the same genotype. #Comparison between genotypes receiving the same treatment. Statistical analysis in B-D was
conducted with ManneWhitney U test. *Comparison between genotypes. Statistical analysis in F (right graph) and G (left graph) was performed with the ManneWhitney U test.
*Comparison between treatments. *,#p < 0.05, **,##p < 0.01, and ***,###p < 0.001.
Original Article
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increased levels was observed in the SIRT1Tgþ mice. At the protein
level, histological and Western blotting analysis of UCP-1 showed a
decrease in both genotypes with a slightly attenuated effect in the
SIRT1Tgþ mice (Figure S3C). Next, to address a possible effect of
inflammation and/or SIRT1 overexpression on BAT respiration, a
Seahorse analysis was conducted in BAT explants from the mice
receiving LPS or not. A trend of higher basal and increased maximal
respiration was found in the SIRT1Tgþ mice (Figure S3D). Moreover,
basal and maximal respiration decreased in BAT explants from the
LPS-injected WT or SIRT1Tgþ mice.
To further evaluate the impact of LPS-mediated inflammation and
SIRT1 overexpression on BAT, we subjected the WT and SIRT1Tgþ
mice to the cold under pro-inflammatory conditions. The mice were
housed at 28 C for 1 week and then randomly divided into 2
experimental groups, one that was exposed to 4 C for 6 h. The other
group was injected with LPS and exposed to 4 C for the last 6 h of a
total of 24 h. Notably, no differences among genotypes were found in
the induction of thermogenic-related genes upon cold exposure
(Figure S4A). The UCP-1 protein levels decreased in BAT from the WT
mice injected with LPS and exposed to 4 C; this effect was amelio-
rated in the SIRT1Tgþmice (Figure 2E). At the mRNA level, Prdm16 and
Dio2 expression significantly decreased after LPS injection plus cold
exposure compared to the cold exposure condition exclusively in the
WT mice (Figure S4B). In line with these data, the rectal and skin BAT
area temperatures significantly decreased in the WT animals after
exposure to LPS and cold compared to the SIRT1Tgþ mice (Figure 2F).
In addition, in the SIRT1Tgþ mice, the BAT and iWAT weight was lower
after LPS injection and cold exposure compared to the WT animals
(Figure S4C). When analyzing BAT histology, fewer nuclei per field
were counted in the WT mice subjected to LPS and cold, an effect not
observed in the SIRT1Tgþ mice (Figure 2G). Overall, these evidences
suggested that LPS promoted impairment of BAT thermogenic capacity
as well as protection by moderate SIRT1 overexpression.
3.3. Moderate SIRT1 overexpression blunted inflammation-induced
impairment in insulin and adrenergic responses in brown adipocytes
We used immortalized brown preadipocytes to identify the molecular
mechanisms related to the protective effects against inflammation
shown by the SIRT1Tgþ mice. In agreement with our previous study
[36], terminally differentiated BA from the SIRT1Tgþ mice (called BA-
SIRT1Tgþ) had lower Ucp1mRNA and UCP-1 protein levels than BA-WT
(Figure S5A). No differences between genotypes were detected in the
protein levels of adipogenic markers such as fatty acid synthase (FAS)
or relevant insulin signaling proteins (IR and GLUT4). We next evaluated
cell autonomous insulin signaling in BA and our data revealed higher
insulin-stimulated IR and AKT phosphorylation in BA-SIRT1Tgþ
(Figure 3A). Notably, these cells showed higher basal AKT phosphor-
ylation in the absence of insulin. Also, as reported by Sun et al. in
skeletal muscle cells [39], moderate SIRT1 overexpression concurred
with the downregulation of protein tyrosine phosphatase 1B (PTP1B)
protein levels in BA (Figure 3B). The impact of moderate SIRT1 over-
expression in the response to norepinephrine (NE) was also evaluated.
BA-SIRT1Tgþ showed a higher NE-induced response on UCP-1
compared with BA-WT (Figure 3C). Moreover, NE-induced lipolysis
as measured by glycerol release to the culture medium was also higher
in BA overexpressing SIRT1 (Figure 3D).
Local proliferation of macrophages in adipose tissues contributes to
inflammation during obesity [51]. To analyze the cross-talk between
macrophages and the BA responses, conditioned medium (CM) was
collected from Raw 267.4 macrophages stimulated or not with LPS
(called CM-LPS and CM-CTR, respectively) and the pro-inflammatoryMOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. This is an open
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(Figure S5B). To analyze the effect of CM-LPS on the activation of pro-
inflammatory signaling cascades, differentiated BA from both geno-
types was treated with either CM for different time periods ranging
from 15 to 120 min. As expected, in BA-WT, the exposure to CM-LPS
triggered an early activation of the signaling pathways mediated by
STAT3, IKKa/b, JNK, and p38 MAPK (Figure S5C). Interestingly, BA-
SIRT1Tgþ showed a significant decrease in STAT3 phosphorylation
compared to BA-WT at all of the time periods analyzed.
We next evaluated the responses of BA to insulin or NE in the presence
of pro-inflammatory CM-LPS. Treatment with CM-LPS decreased
insulin-mediated IR and AKT phosphorylation in BA-WT compared with
the response in the presence of CM-CTR (Figure 3E). However, this
effect was ameliorated in BA-SIRT1Tgþ. Since BAT is a glucose-
clearing organ [52], the effect of the pro-inflammatory environment
on glucose uptake was measured in BA. We observed an increase in
basal (insulin-independent) glucose uptake in BA-WT after the treat-
ment with CM-LPS that was absent in BA-SIRT1Tgþ. Notably, BA
overexpressing SIRT1 showed higher basal levels of glucose uptake
under non-pro-inflammatory conditions (CM-CTR) that did not further
increase in the presence of CM-LPS (Figure 3F). The analysis of the
insulin response revealed a marked reduction in glucose uptake in BA-
WT pre-treated with CM-LPS that did not occur in BA-SIRT1Tgþ. In the
same line, the response of BA to NE in the presence of CM-LPS evi-
denced a decrease in UCP-1 protein levels in BA-WT (Figure 3G).
Unexpectedly, SIRT1 overexpression failed to protect against the
decrease in UCP-1 protein content, although his reduction was less
evident at the mRNA level.
3.4. Differentiation of brown adipocytes in medium enriched in T3,
insulin, and rosiglitazone enhanced their thermogenic program
To overcome the failure of BA-WT and BA-SIRT1Tgþ to respond to NE
under pro-inflammatory conditions, preadipocytes were differentiated
using a protocol previously used by Quesada-López et al. to differ-
entiate subcutaneous white adipocytes into beige adipocytes [44], but
not previously used to differentiate BA. This differentiation medium
(called medium 2) is enriched in T3, rosiglitazone, and insulin
compared to the medium broadly used to differentiate brown pre-
adipocytes (called medium 1; see Materials and Methods). Although
the differentiation of preadipocytes from both genotypes with either
medium was comparable (Figure 4A, left panel), staining of lipid
droplets with Bodipy revealed higher lipid accumulation in BA differ-
entiated with medium 2 (Figure 4A, right panel). Interestingly, Dio2
mRNA levels were downregulated in both BA genotypes differentiated
in medium 2 compared to medium 1 (Figure 4B), probably due to
elevated T3 concentrations [53]. BA-WT differentiated with medium 2
showed a marked increase in Prdm16 mRNA levels compared with the
levels found in these cells upon differentiation with medium 1.
Importantly, Prdm16 expression was elevated regardless of the dif-
ferentiation medium in BA-SIRT1Tgþ. Moreover, both BA-WT and BA-
SIRT1Tgþ showed much higher Ucp1 mRNA and UCP-1 protein levels
at the final stage of differentiation with medium 2 compared to medium
1 (Figure 4B). However, no differences in Pgc1a mRNA levels were
found regardless of the genotype or differentiation medium.
We next investigated if medium 2 could affect the metabolism of BA.
Metabolomic analysis revealed an increase in metabolites of the
tricarboxylic acid cycle (TCA) such as a-ketoglutarate, succinate, and
glutamic acid but not glutamine compared to the levels detected in
both BA genotypes differentiated with medium 1 (Figure 4C). Moreover,
an increase in ribose and gluconic acid lactone, intermediates of the
phosphate pentose cycle (PPC), was found in BA differentiated withaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 9
Figure 4: Differentiation of BA from the WT and SIRT1TgD mice with T3, insulin, and rosiglitazone-enriched medium impacted the metabolic and thermogenic profiles.
(A) Microscopy images and Bodipy immunofluorescence (red) in BA differentiated with medium 1 or 2. Scale bars represent 20 mm. (B) (left) Dio2, Ucp1, Prdm16, and Pgc1a mRNA
levels in BA on day 7 of differentiation with the two media analyzed by qRT-PCR relative to levels on day 0 (n ¼ 5e6 independent experiments). (right) Representative Western
blotting and quantification of UCP-1 protein levels on days 0 and 7 of differentiation of BA with medium 1 or 2 (n ¼ 4 independent experiments). (C) Metabolomic analysis in BA
differentiated with medium 1 or 2 (day 7) (n ¼ 2e3 independent experiments). Results are expressed as mean  SEM. Statistical analysis in B (right) was performed with Manne
Whitney U test. *Comparison between genotypes. The statistical analysis in B (left) and C was conducted by two-way ANOVA. (B) (left) *Comparison between different genotypes
and the same medium. #Comparison between the two media and the same genotype. (C) *Comparison between the same genotype and different media. #Comparison between
genotypes differentiated with the same medium. *,#p < 0.05, **,##p < 0.01, and ***,###p < 0.001. P.S., Ponceau staining.
Original Articlemedium 2. Likewise, the antioxidant metabolite myo-inositol was also
increased. These results demonstrate an effect of medium 2 on the
metabolic profile of differentiated BA in a SIRT1-independent manner.
We also addressed a possible effect of medium 2 in the amount of
mitochondria in BA by performing TOM 22 and COX-IV immunofluo-
rescence. A higher signal of both markers was detected in BA over-
expressing SIRT1 (Figure S6A). Mitochondrial mass was also
measured by flow cytometry using MitoTracker Green. Although BA-
SIRT1Tgþ showed significantly higher mitochondrial mass compared to10 MOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. TBA-WT upon differentiation with medium 1, medium 2 led to differ-
entiated BA of the two genotypes with less mitochondrial mass.
Mitochondrial dynamics was also studied in BA on day 7 with either
differentiation medium by immunofluorescence and Western blotting
of phosphorylated DRP1 (p-DRP1) and mitofusin 2 (MFN2) as markers
of mitochondrial fission and fusion, respectively. Our results showed
higher p-DRP1 levels in BA-WT and BA-SIRT1Tgþ differentiated with
medium 2 while MFN2 decreased (Figure S6B), demonstrating similar
changes in mitochondrial dynamics.his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 5: Differentiation of brown adipocytes in medium enriched in T3, insulin, and rosiglitazone conferred protection against inflammation in insulin and
noradrenergic responses. (A) Western blotting and quantification of insulin-induced AKT phosphorylation (n ¼ 3 independent experiments). (B) Western blotting and quantification
of UCP-1 (n ¼ 4 independent experiments) and Ucp1 mRNA levels (n ¼ 2e3 independent experiments) after differentiation of BA with medium 2 and treatment with CM-CTR or
CM-LPS in the absence or presence of NE. Results are expressed as mean  SEM. Statistical analysis was performed by two-way ANOVA. (A) #Comparison between genotypes
with the same treatment. (B) *Comparisons between NE-treated and untreated BA with the same genotype. Bars represent mean  SEM. *,#p < 0.05, **p < 0.01, and
***p < 0.001.To study the responses to insulin or NE in BA differentiated with
medium 2, we analyzed insulin signaling as well as UCP-1 protein and
its mRNA levels after the same treatments described for medium 1
(Figure 3A,B, and C). Data on insulin signaling showed higher basal IR
and AKT phosphorylation in BA-SIRT1Tgþ and a marked tendency to
increase in their response to insulin (Figure S6C). Of note, as occurred
in the cells differentiated in medium 1 (Figure 3B), the PTP1B protein
levels remained downregulated in BA-SIRT1Tgþ differentiated with
medium 2 (Figure S6D). Medium 2 also led to higher Ucp1mRNA levels
in NE-treated BA-WT or BA-SIRT1Tgþ (Figure 6E); this effect was even
enhanced by SIRT1 overexpression. Regarding UCP-1 protein levels,
an increased response to NE was detected in BA-SIRT1Tgþ differen-
tiated with medium 2, an effect due in part to reduced basal levels.
Likewise, BA-SIRT1Tgþ showed a higher NE-induced lipolytic rate
compared to the response of BA-WT (Figure S6E). Comparison be-
tween the effect of NE in increasing Ucp1 mRNA levels in BA differ-
entiated with each medium revealed a fourfold increase in both BA
genotypes differentiated with medium 2 (Figure S6F).
Taking into account the relationship between T3 and SIRT1 [24], we
hypothesized that medium 2 might modulate SIRT1 activity. The
analysis of p65-NFkB acetylation as a readout revealed a decrease in
BA-WT differentiated with medium 2 (Figure S7A). As expected, SIRT1
overexpression decreased acetylation of p65-NFkB in BA differentiated
with either medium 1 or 2. Lower ATP levels were detected in both
genotypes after differentiation with medium 2 (Figure S7B). This
decrease in ATP levels could be indicative of higher SIRT1 activity as
previously reported [54]. In agreement, BA-SIRT1Tgþ showed lower
ATP levels than those of BA-WT regardless of the differentiationMOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. This is an open
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modulate ATP levels in BA. For this purpose BA were stimulated with
CM-CTR or CM-LPS. Treatment with CM-LPS decreased ATP levels in
BA-WT differentiated with either medium 1 or 2. In contrast, ATP levels
did not further decrease in BA-SIRT1Tgþ differentiated with medium 2
(Figure S7C).
3.5. Differentiation of brown adipocytes in medium enriched in T3,
insulin, and rosiglitazone conferred protection against pro-
inflammatory conditions
We investigated whether medium 2 would confer protection against
the activation of pro-inflammatory signaling cascades and subsequent
reduction in insulin and noradrenergic responses induced by CM-LPS.
This analysis revealed lower activation of STAT3 in BA-WT differenti-
ated with medium 2 with respect to the response in medium 1
(Figure S8A) and moderately less activation of the inflammatory cas-
cades in BA-SIRT1Tgþ (Figure S8B). In the same line of the results
obtained with medium 1 (Figure 3A,3E), moderate SIRT1 over-
expression enhanced insulin-mediated AKT phosphorylation and pro-
tected against the decrease in this response in the presence of pro-
inflammatory CM-LPS (Figure 5A). We also assessed whether differ-
entiation of BA with medium 2 could prevent the decline in NE-induced
UCP-1 activation under pro-inflammatory conditions. Contrary to the
results depicted in Figure 3G, both BA genotypes differentiated in
medium 2 increased UCP-1 protein and Ucp1 mRNA levels in response
to NE in the presence of CM-LPS (Figure 5B).
Seahorse analysis was conducted to study more in-depth mito-
chondrial respiration capacity of BA upon differentiation with eitheraccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 11
Original Articlemedium 1 or 2 and treatment with pro-inflammatory CM-LPS. Fatty
acid oxidation (FAO) was also measured to evaluate their oxidative
capacity. The Seahorse profile revealed no impact of the pro-
inflammatory environment on the complexes of the electron trans-
port chain (ETC) in BA differentiated with medium 1 (Figure 6A).
Likewise, no differences were found in the effect of oligomycin,
FCCP, or rotenone/antimycin A. Regarding FAO analyzed by detecting
CO2 and acid-soluble products (ASPs) released from oxidation of
palmitate, BA-SIRT1Tgþ showed higher basal levels that decreased
after treatment with CM-LPS but remained higher than those of BA-
WT. Similar research was conducted in BA differentiated with me-
dium 2 and the Seahorse profile revealed increased basal OCR
compared to medium 1 (Figure 6A,B). Moreover, increased OCR wasFigure 6: A pro-inflammatory environment impacted the Seahorse, metabolic profile
insulin, and rosiglitazone-enriched medium. (A) Seahorse profile and FAO assay in B
dependent experiments). (B) Seahorse profile (one experiment performed in quintupled) an
treated with CM-CTR or CM-LPS for 18 h. (C) Metabolomic analysis in BA differentiated
experiments). In A and B, statistical analysis was conducted with the ManneWhitney U
genotypes. In C, the statistical analysis was performed by two-way ANOVA. *Comparison b
between genotypes with the same treatment. *Comparison between genotypes. Bars rep
12 MOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. Talso found in BA-WT differentiated with medium 2 after treatment
with CM-LPS (blue lines in Figure 6B). However, we did not find
differences in the impact of the pro-inflammatory environment on
OCR levels in BA-SIRT1Tgþ (purple and pink lines). In addition, FAO
analysis revealed an increase in CO2 and ASPs released from
palmitate oxidation in BA-SIRT1Tgþ after treatment with CM-CTR or
CM-LPS compared to the BA-WT levels (Figure 6B). Moreover, the
metabolomic analysis in BA differentiated with medium 2 showed a
marked increase in a-ketoglutarate and succinate, both TCA me-
tabolites related to anti-inflammatory responses in macrophages
[55,56] and glycerol as well as a tendency to increase in glutamine in
BA-SIRT1Tgþ after exposure to CM-LPS (Figure 6C). However, these
effects were absent in BA-WT.s, and noradrenergic response of BA-WT and BA-SIRT1TgD differentiated with T3,
A differentiated with medium 1 treated with CM-CTR or CM-LPS for 18 h (n ¼ 3 in-
d FAO assay (n ¼ 3 independent experiments) in BA differentiated with medium 2 and
with medium 2 and treated with CM-CTR or CM-LPS for 18 h (n ¼ 2e3 independent
test. *Comparison of ASPs between genotypes. #Comparison of CO2 levels between
etween CM-LPS and CM-CTR-treated BA differentiated in same genotype. #Comparison
resent mean  SEM. *,#p < 0.05, **,##p < 0.01, and ***p < 0.001.
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Figure 7: Differences in plasma and BAT THs levels in the WT and SIRT1TgD mice after inflammation and cold exposure. Effect of resveratrol in BAT from the db/db
mice. (A) T3 and T4 levels in plasma and BAT at thermoneutrality or after cold exposure (n ¼ 5e10 mice/group). (B) Fold change of T3 and T4 levels in plasma and BAT after cold
exposure of LPS-injected or non-injected mice (n ¼ 7e13 mice/group). Data are referred to the WT group maintained at 28 C. (C) Western blotting and quantification of UCP-1
levels in BA differentiated in medium 1 supplemented with T3 (n ¼ 3 independent experiments) (D) (left) Graphs show Dio2, Fgf21, and Ucp1 mRNA levels in BAT (n ¼ 3e4 mice/
group) from the db/db mice treated with resveratrol. (middle) Representative western blotting showing UCP-1 levels in BAT and quantification (n ¼ 3e4 mice/group). (right)
Circulating FGF21 levels. Results are expressed as mean  SEM. The statistical analysis in A-B was performed with two-way ANOVA. *Comparison between the mice at 28 C and
4 C or between the LPS-injected or non-injected mice. #Comparison between the same conditions and different genotypes. In C, statistical analysis was conducted with two-way
ANOVA. *Comparison between CM-LPS and CM-CTR-treated BA differentiated in the same genotype. In D, statistical analysis was performed with the ManneWhitney U test.
*,#p < 0.05, **p < 0.01, and ***,###p < 0.001.3.6. T3 and T4 in plasma and BAT were modulated in SIRT1
Tgþ
mice exposed to LPS and cold
As the in vitro data established a direct relationship between differ-
entiation of BA in the presence of high T3 levels and increased UCP-1
under normal or pro-inflammatory conditions, we analyzed T3 and T4MOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. This is an open
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both pro-inflammatory and thermogenic conditions. The WT and
SIRT1Tgþ mice showed increased T3 levels in their circulation and BAT
upon cold exposure; the abundance of intra-BAT T3 was higher in the
SIRT1Tgþ mice challenged with cold (Figure 7A). However, afteraccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 13
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trend (non-significant) of less decrease in T3 plasma levels compared
to the WT mice and significant protection against the decrease in intra-
BAT T3 content (Figure 7B). The combination of LPS injection and cold
exposure equally decreased circulating T4 in both mouse genotypes
and did not affect the intra-BAT content of T4 although the SIRT1
Tgþ
mice had higher levels. The relationship between SIRT1 and T3 was
also tested in BA differentiated with medium 1 and supplemented with
only T3 up to a similar concentration as in medium 2. As shown in
Figure 7C, under this condition, BA-SIRT1Tgþ were more sensitive to
NE in the presence of CM-LPS compared to BA-WT.
3.7. Resveratrol increased Dio2 mRNA levels and UCP-1
expression in BAT in the db/db mice
To enhance UCP-1 protein in BAT using a pharmacological approach
targeting THs and SIRT, we treated the db/dbmice with SIRT1 activator
resveratrol. Treatment of the db/db mice with resveratrol for 8 weeks
decreased their blood glucose without changes in body weight
(Figure S1F,S1G). Interestingly, increased Dio2 and Fgf21 mRNA
levels, the latter recently associated by Villarroya et al. with increases
in UCP-1 [15], were found in BAT from the resveratrol-treated db/db
mice in parallel with elevations in circulating FGF21 and increased
UCP-1 expression in the mRNA and protein levels in BAT (Figure 7D).
4. DISCUSSION
Pro-inflammatory signals have recently been recognized as potential
negative modulators of BAT functionality. The results presented herein
evidenced inflammatory features in BAT from the db/db mice man-
ifested by enhanced pro-inflammatory signaling and gene expression
in this fat depot, an effect that correlated with tissue-specific insulin
resistance as reported in other organs [57e60]. Of relevance, as
occurred in the muscle or liver in insulin-resistant states [61,62], an
altered IRA/IRB ratio was found in BAT from the db/db mice with a
robust IRA presence that could account, at least in part, for the
impaired insulin signaling, an effect likely due to metabolic immaturity
of this tissue. Whether the unbalanced IRA/IRB ratio in BAT from the
db/db mice was a direct consequence of systemic and/or local
inflammation deserves future research.
Seeking a causative factor for the onset of inflammation-mediated
insulin resistance in BAT, we explored whether endotoxemia was
sufficient to trigger pro-inflammatory signaling cascades in this tissue.
Based on previous studies [63,64], we injected a non-septic dose of
LPS into the WT mice and found a pro-inflammatory signaling signa-
ture in BAT similar to that of the db/db mice. Of note, these pathways
negatively impact insulin signaling at different levels [65e67] and are
likely responsible for the impairment of IR and AKT phosphorylation in
BAT from the LPS-injected or db/db mice.
Several studies have reported a role of SIRT1 in the protection against
metabolic damage linked to obesity [33,34,36] and its benefit in
alleviating LPS-induced metabolic dysfunction in lung [68], keratino-
cyte [69], or endothelial cells [70]. Our study provides previously un-
known evidence of the protection against the decline in IR and AKT
phosphorylation in BAT from LPS-injected SIRT1Tgþ mice in line with
the recently reported alleviation of fatty liver by SIRT1 activation [71].
The in vitro studies in BA with moderate SIRT1 overexpression showed
increased insulin-induced IR and AKT phosphorylation compared to
BA-WT in parallel with reduced PTP1B protein levels. This agrees with
the work of Sun et al. on improving insulin sensitivity in hepatocytes
and myotubes by enhancing SIRT1 expression/activity through
repression of PTP1B [39]. A step further and to verify the protective14 MOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. Teffect of moderate SIRT1 overexpression in BA in an inflammatory
context, we conducted cell-based experiments mimicking their cross-
talk with macrophages. The decrease in STAT3 phosphorylation in BA-
SIRT1Tgþ treated with pro-inflammatory CM-LPS suggests specific
modulation of the JAK-STAT pathway by SIRT1 in BA [72]. Further-
more, BA-SIRT1Tgþ were protected against the decline in insulin-
mediated IR and AKT phosphorylation under pro-inflammatory condi-
tions compared to BA-WT, probably by synergy of lower PTP1B and
less STAT3 phosphorylation, the latter described in 3T3L1 adipocytes
demonstrating a relationship between SOCS3, STAT3, and insulin
signaling in adipose cells [73e75]. Of relevance, in both WT and SIRT1
overexpressing BA, the impact of the pro-inflammatory CM was higher
in the AKT phosphorylation response. This was likely due to alternative
mechanisms triggered by pro-inflammatory cytokines such as
increased SOCS3 [75], which impairs insulin receptor substrate-1-
mediated signaling downstream IR and upstream AKT. Of note, the
inflammatory CM-LPS upregulated basal (insulin-independent) glucose
uptake in BA-WT, thereby ameliorating the effect of insulin as occurred
in myotubes and white adipocytes treated with TNFa, IL-1b, or IL-6
[76e78], an effect probably mediated by the upregulation of GLUT-1
[79]. Moreover, the pro-inflammatory CM-LPS led to a decrease in
insulin-induced glucose uptake in BA-WT as found in other insulin-
sensitive cells including white adipocytes [80] that might be related
to the decrease in AKT phosphorylation [81]. In contrast, in BA-
SIRT1Tg,þ CM-LPS did not increase insulin-independent glucose up-
take or decrease insulin-mediated glucose uptake under pro-
inflammatory conditions and preserved the threshold AKT phosphor-
ylation levels. Our results agree with Yoshizaki et al., showing that
SIRT1 activators increased glucose uptake and insulin signaling in
white adipocytes and rescued from TNF-a-induced insulin resistance
[82]. Likewise, Chen et al. described that SIRT1 activation by resver-
atrol increased glucose uptake in insulin-resistant 3T3-L1 adipocytes
[83].
Although evidence of the involvement of SIRT1 in increasing energy
expenditure has been reported [33,34,36], the impact of its moderate
overexpression/activation in BAT thermogenesis under a pro-
inflammatory context has not been explored. Of note, SIRT1 over-
expression was associated with enhanced energy expenditure and
transcriptional responses to b-adrenergic stimulation in BAT
[33,36,84e86]. In agreement with those previous studies, herein we
showed elevations in the temperature of the skin BAT area, as well as
in basal and maximal respiration, in BAT explants from the SIRT1Tgþ
mice in parallel with higher UCP-1 protein and mRNA levels. Inter-
estingly, histological evaluation revealed lipid-depleted BAT sections in
the mice with moderate overexpression of SIRT1, a feature of tissue
activation. This BAT morphology likely resulted from the increased
basal lipolytic rate as we previously reported [36]. However, after
exposing the mice to thermoneutrality followed by cold challenge, we
did not detect differences in thermogenic-related genes among the
mice without or with moderate SIRT1 overexpression. These data differ
from those of Gerhart-Hines et al. that found increased basal and cold-
induced Ucp1 mRNA in BAT from SirBACO mice [84]. A potential
explanation for such differences can be attributed to different mice
strains and the absence of thermoneutral conditions before cold
exposure in their study. Regarding the impact of inflammation in BAT
independent of obesity, Nohr et al. reported reduced expression of
brown-related genes in mice chronically infused LPS, an effect
associated with a switch in polarization of BAT resident macrophages
to the M1 state [87]. A step further, our results in mice exposed to LPS
and cold revealed that moderate SIRT1 overexpression protected
against decreases in rectal temperature, skin BAT area temperature,his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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and the decline in UCP-1 protein levels. In addition, histology of the
BAT sections showed a further decrease in the lipid content in the
SIRT1Tgþ mice, suggesting a more effective utilization of lipids stored
in BAT droplets as thermogenic fuel to maintain body temperature.
To obtain further insight into the cell-autonomous effects of moderate
SIRT1 overexpression, we studied the response of BA-WT and BA-
SIRT1Tgþ to NE. Previous results showed that terminally differentiated
BA from SIRT1Tgþ mice expressed less UCP-1 under basal conditions
[36], in line with the role of SIRT1 as a metabolic sensor triggering
adaptations to optimize energy production [88]. In contrast and in
agreement with this previous study, BA-SIRT1Tgþ showed higher Ucp1
mRNA and protein levels upon b-adrenergic stimulation, demon-
strating their better responsiveness upon a thermogenic stimulus. Of
relevance, the results presented herein revealed that Ucp1 mRNA and
protein levels decreased in BA-WT exposed to CM-LPS and NE as pro-
inflammatory and b-adrenergic stimuli, respectively. In this line, the
suppression of isoproterenol-induced UCP-1 activation by
macrophage-derived CM was reported in 10T1/2 adipocytes derived
from mouse mesenchymal stem cells [89]. However, we found an
unexpected response in BA-SIRT1Tgþ in which the pro-inflammatory
milieu impaired their response to NE in inducing UCP-1 as in BA-
WT. Of note, the expression or activity of SIRT1 were attenuated by
LPS in endothelial cells [70], Kupffer cells [90], and Raw 264.7
macrophages [90e92]. Therefore, the failure of moderate SIRT1
overexpression to counteract the decline in UCP-1 in BA in a pro-
inflammatory environment might be due to a decrease in SIRT1 ac-
tivity under this condition. Of note, the different results found in BA vs
BAT from the SIRT1Tgþ mice regarding the protection against the
decline in UCP-1 under pro-inflammatory conditions could have been
due to the anti-inflammatory effect of cold-induced M2 polarized
resident macrophages in BAT tissue [93] that might have counteracted
LPS-induced inflammation.
To find an alternative protocol to differentiate brown preadipocytes to
mature cells resistant to the deleterious effects of CM-LPS, we adapted
a method used for inducing “browning” of inguinal white adipocytes
[44]. This medium (called medium 2) was enriched in insulin, rosi-
glitazone, and T3, all major triggers of BAT adipogenic and thermo-
genic programs [2,94,95]. T3 is classically considered a stabilizer of
Ucp1 mRNA levels [17,18] as evidenced by increased Ucp1 mRNA and
UCP-1 protein levels upon differentiation of BA with medium 2. This
effect was not related to changes in Pgc1a and was markedly
enhanced in BA-SIRT1Tgþ that presented very low UCP-1 protein levels
upon differentiation in medium 1 as previously mentioned. A possible
factor contributing to the increased UCP-1 levels in terminally differ-
entiated BA in medium 2 could have been related to a switch in
mitochondrial dynamics revealing, on the one hand, lower fusion
(MFN2) in parallel with less ATP levels as reviewed by Lee et al. [96]
and, on the other hand, higher p-DRP1, a readout of fission, in
agreement with elevated p-DRP1 reported in activated BAT and also
with reduced uncoupled respiration in BA by the blockade of mito-
chondrial fission [97,98].
T3 increases intracellular NAD
þ/NADH and activates SIRT1 in both
hepatocytes and BA [24] and also increases SIRT1 expression and
activity in livers of rats treated with rosiglitazone [99]. Therefore, we
demonstrated higher SIRT1 activation monitored by reduced p65-
NFkB acetylation in BA differentiated with medium 2. However, we
could not distinguish if BA-SIRT1Tgþ differentiated in medium 2 dis-
played higher SIRT1 enzymatic activity compared with BA-WT or BA-
SIRT1Tgþ differentiated in medium 1. Because commercially available
tools to measure SIRT1 enzymatic activity have limited sensitivity, we
indirectly addressed this issue by measuring ATP levels since KangMOLECULAR METABOLISM 42 (2020) 101097  2020 The Author(s). Published by Elsevier GmbH. This is an open
www.molecularmetabolism.comet al. demonstrated suppression of SIRT1 enzymatic activity by ATP
[54]. In this regard, BA differentiated with medium 2 showed a sub-
stantial decrease in ATP levels; this effect was more pronounced in BA-
SIRT1Tgþ. Of interest was the increase in Prdm16 mRNA levels in BA-
WT differentiated with medium 2. Ohno et al. suggested that the
“browning” effect of PPAR ligands, including rosiglitazone, is due to
stabilization of PRDM16 protein [100]. Taking into account this study,
rosiglitazone per se and its effects mediated by PRDM16 likely
contributed to enhanced UCP-1 levels in BA-WT differentiated with
medium 2. Interestingly, as will be discussed, the supplementation of
medium 1 with T3 was sufficient to confer protection against the
decline in UCP-1 by CM-LPS only in BA-SIRT1Tgþ that already showed
higher Prdm16 mRNA levels upon differentiation with medium 1
compared to BA-WT. Medium 2 also contained a high concentration of
insulin that in adipocytes favors fatty acid storage as triacylglycerol
species in lipid droplets [101], an effect exacerbated in both BA ge-
notypes differentiated under this condition. A metabolomic analysis
was conducted to further explore differences in terminally differenti-
ated BA with either medium. We detected an increase in a-ketoglu-
tarate and succinate, two key TCA metabolites previously related to the
suppression of IKKb activation [55] or promotion of M2 polarization in
macrophages [56], respectively, in BA differentiated with medium 2.
The accumulation of succinate increased succinate dehydrogenase
activity, resulting in the generation of reactive oxygen species that
increased UCP-1 expression [102] and, in this line, we observed a
direct relationship between the increase in succinate and UCP-1 in
both BA genotypes differentiated in this medium. In fact, the elevation
of these two intermediary TCA metabolites (succinate and a-keto-
glutarate) could cooperate with the increased b-oxidation found in BA
differentiated with medium 2, particularly in BA-SIRT1Tgþ, that showed
a higher b-oxidation rate under basal conditions or in the presence of
CM-LPS. Notably, a-ketoglutarate acts as a metabolic regulator that
can also increase FAO [55]. Moreover, the anabolic PPC generates
NADPH necessary for the lipogenic program and confers antioxidant
properties. In this regard, we detected higher levels of ribose and
gluconic acid lactone after differentiation of both BA genotypes with
medium 2. In the same line, myo-inositol, a metabolite with direct
antioxidant activity [103], also increased. Of interest is the increase in
glycerol after LPS treatment in BA-SIRT1Tgþ differentiated with me-
dium 2 compared to BA-WT. This metabolite could be derived from the
hydrolysis of triglycerides contained in BA lipid droplets generating
FFAs as thermogenic fuel. Altogether, the results of the metabolomic
analysis demonstrate the benefit of medium 2 in yielding differentiated
BA with an anti-inflammatory metabolic signature.
Regarding insulin signaling and glucose uptake in a pro-inflammatory
context, the results did not differ from medium 1, including the
downregulation of PTP1B in BA-SIRT1Tgþ and the rescue from insulin
resistance. Conversely, both BA genotypes preserved the response to
NE under pro-inflammatory conditions in increasing UCP-1 levels in
medium 2 but, as previously mentioned, the enrichment in only T3 was
sufficient to rescue BA-SIRT1Tgþ, highlighting the cooperation of T3
and SIRT1. It was previously suggested that in addition to the direct
effects in BAT, THs also act indirectly via hypothalamic stimulation of
sympathetic innervation, revealing a central role of T3 in the
hypothalamus-BAT axis by inducing lipolysis and mitochondrial
uncoupling [104,105]. In agreement, we observed higher lipolysis in
the two BA genotypes differentiated with medium 2 and, importantly,
this response was more pronounced in BA-SIRT1Tgþ. In line with this,
BAT from the SIRT1Tgþ mice showed lipid-depleted BAT sections.
During cold exposure, sympathetic stimulation of BAT increases Dio2
expression and raises intracellular T3 content that, in turn, stimulatesaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 15
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metabolism [18]. In this context, we detected higher circulating T3
levels in the WT and SIRT1Tgþ mice after cold exposure. Although LPS
impairs thyroid function, decreasing serum T3, T4, and TSH [106e
109], SIRT1 has been described on the one hand to activate THs re-
ceptor b1 in the liver [110] and, on the other hand, to mediate a
positive regulation of TSH secretion [111]. In this regard, we found a
decline in T3 and T4 levels in the mice from both genotypes challenged
with LPS and cold; this effect was attenuated in the SIRT1Tgþmice that
preserved higher intra-BAT T3 levels and this might be responsible, at
least in part, for the beneficial effects observed in the thermogenic-
related parameters studied and previously discussed. Altogether, our
results demonstrate the specific relevance of T3, which was enriched
in medium 2, in the SIRT1Tgþmice rather than insulin since those mice
showed similar circulating insulin levels as the WT [34,36]. These
results were also supported by the rescue of the decline in UCP-1
levels in db/db mice treated with resveratrol as recently reported by
Hui et al. [112] and also found in our study, likely related to the
elevation in Dio2 isoform that converts local T4 to T3 in BAT tissue [113]
as well as increased Fgf21 expression.
5. CONCLUSIONS
Hypothyroid patients showed decreased adaptive thermogenesis
during cold exposure that was corrected by thyroid hormone
replacement [114]. Thus, this study’s results might have a translational
impact on the treatment of obesity and other metabolic diseases,
suggesting the use of combinatorial therapies of BAT-specific thyro-
mimetics, with potentially fewer side effects than THs, along with
SIRT1 activators.
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